Benitec Biopharma Inc BNTC

US Biotechnology

$9.59 ▼ -0.52% ($-0.05)

Open $9.70

Prev Close $9.64

Day Range $9.31 – $9.80

52W Range $9.26 – $16.76

Market Cap $334.53M

Beta 0.25

EPS (TTM) $-1.11

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2012-07-11
Shares Out.	34,350,000
Website	benitec.com/ ↗
Phone	15107800819
Employees	24
Revenue	$0
Gross Profit	$0
Net Income	-$12.8M
Free Cash Flow	-$16.6M
Total Assets	$182.6M
Total Liabilities	$5.6M
Equity	$177.0M

About Benitec Biopharma Inc

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Benitec Biopharma Inc is a publicly traded company under the ticker symbol BNTC on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.